SCHEMBL17825358

SCHEMBL17825358

Cc1nnc(Cn2c(=O)[nH]c3ccc(S(N)(=O)=O)c(C4(CF)CC4)c3c2=O)s1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17825247 0.80 PARG (0.53) PARG
SCHEMBL17845654 0.76 PARG (0.45) PARG
SCHEMBL17825422 0.69 PARG (0.39) PARG
SCHEMBL17832079 0.66 PARG (0.79) PARG
SCHEMBL17824813 0.66 ALDH1A1 (0.58) PARG
SCHEMBL17825243 0.66 PARG (0.67) PARG
SCHEMBL28533960 0.66 PARG (0.51) PARG
SCHEMBL28531567 0.62 PARG (0.57) PARG
SCHEMBL28176791 0.57 LMNA (0.39) PARG
SCHEMBL17825266 0.56 PARG (1.00) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230273-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG Cancer Research Technology Ltd (GB) 2017-10-18 EP disclosed
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed